TY - JOUR AU - Guariguata, L. AU - Whiting, D. R. AU - Hambleton, I. AU - Beagley, J. AU - Linnenkamp, U. AU - Shaw, J. E. PY - 2014 DA - 2014// TI - Global estimates of diabetes prevalence for 2013 and projections for 2035 JO - Diabetes Res Clin Pract VL - 103 UR - https://doi.org/10.1016/j.diabres.2013.11.002 DO - 10.1016/j.diabres.2013.11.002 ID - Guariguata2014 ER - TY - JOUR AU - Campbell, R. K. PY - 2006 DA - 2006// TI - Rationale for Dipeptidyl Peptidase 4 Inhibitors: A New Class of Oral Agents for the Treatment of Type 2 Diabetes Mellitus JO - Ann Pharmacother VL - 41 UR - https://doi.org/10.1345/aph.1H459 DO - 10.1345/aph.1H459 ID - Campbell2006 ER - TY - JOUR AU - Yousefzadeh, P. AU - Yousefzadeh, P. AU - Wang, X. AU - Wang, X. PY - 2013 DA - 2013// TI - The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus JO - J Diabetes Res VL - 2013 UR - https://doi.org/10.1155/2013/459821 DO - 10.1155/2013/459821 ID - Yousefzadeh2013 ER - TY - JOUR AU - Rosenstock, J. AU - Zinman, B. PY - 2007 DA - 2007// TI - Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus JO - Curr Opin Endocrinol Diabetes Obes VL - 14 UR - https://doi.org/10.1097/MED.0b013e3280a02f65 DO - 10.1097/MED.0b013e3280a02f65 ID - Rosenstock2007 ER - TY - JOUR PY - 2014 DA - 2014// TI - Guideline of Prevention and Treatment for T2DM in China (2013) JO - Chin J Diabetes Mellitus VL - 6 ID - ref5 ER - TY - JOUR AU - Pan, C. AU - Xing, X. AU - Han, P. AU - Zheng, S. AU - Ma, J. AU - Liu, J. AU - Lv, X. AU - Lu, J. AU - Bader, G. PY - 2012 DA - 2012// TI - Efficacy and tolerability of vildagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes mellitus JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01593.x DO - 10.1111/j.1463-1326.2012.01593.x ID - Pan2012 ER - TY - JOUR AU - Jadad, A. R. AU - Moore, R. A. AU - Carroll, D. AU - Jenkinson, C. AU - Reynolds, D. J. M. AU - Gavaghan, D. J. AU - McQuay, H. J. PY - 1996 DA - 1996// TI - Assessing the quality of reports of randomized clinical trials: Is blinding necessary? JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(95)00134-4 DO - 10.1016/0197-2456(95)00134-4 ID - Jadad1996 ER - TY - STD TI - Viechtbauer W. metafor: Meta-Analysis Package for R. http://www.metafor-project.org/doku.php. Accessed Sept 2014. UR - http://www.metafor-project.org/doku.php ID - ref8 ER - TY - JOUR AU - Higgins, J. P. T. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Statist Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - Higgins2002 ER - TY - JOUR AU - Egger, M. AU - Smith, G. D. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Yang, W. AU - Guan, Y. AU - Shentu, Y. AU - Li, Z. AU - Johnson Levonas, A. O. AU - Engel, S. S. AU - Kaufman, K. D. AU - Goldstein, B. J. AU - Alba, M. PY - 2012 DA - 2012// TI - The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes*† JO - J Diabetes VL - 4 UR - https://doi.org/10.1111/j.1753-0407.2012.00213.x DO - 10.1111/j.1753-0407.2012.00213.x ID - Yang2012 ER - TY - STD TI - Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121). https://clinicaltrials.gov/ct2/show/NCT01076088. Accessed Aug 2014. UR - https://clinicaltrials.gov/ct2/show/NCT01076088 ID - ref12 ER - TY - STD TI - Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130). http://clinicaltrials.gov/ct2/show/NCT01177384. Accessed Aug 2014. UR - http://clinicaltrials.gov/ct2/show/NCT01177384 ID - ref13 ER - TY - JOUR AU - Mohan, V. AU - Yang, W. AU - Son, H. -. Y. AU - Xu, L. AU - Noble, L. AU - Langdon, R. B. AU - Amatruda, J. M. AU - Stein, P. P. AU - Kaufman, K. D. PY - 2009 DA - 2009// TI - Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea JO - Diabetes Res Clin Pract VL - 83 UR - https://doi.org/10.1016/j.diabres.2008.10.009 DO - 10.1016/j.diabres.2008.10.009 ID - Mohan2009 ER - TY - JOUR AU - Yang, W. AU - Xing, X. AU - Lv, X. AU - Li, Y. AU - Ma, J. AU - Yuan, G. AU - Sun, F. AU - Wang, W. AU - Woloschak, M. AU - Lukashevich, V. AU - Kozlovski, P. AU - Kothny, W. PY - 2015 DA - 2015// TI - Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitus JO - J Diabetes VL - 7 UR - https://doi.org/10.1111/1753-0407.12169 DO - 10.1111/1753-0407.12169 ID - Yang2015 ER - TY - JOUR AU - Zeng, Z. AU - Yang, J. -. K. AU - Tong, N. AU - Yan, S. AU - Zhang, X. AU - Gong, Y. AU - Woerle, H. -. J. PY - 2013 DA - 2013// TI - Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial JO - Curr Med Res Opin VL - 29 UR - https://doi.org/10.1185/03007995.2013.805123 DO - 10.1185/03007995.2013.805123 ID - Zeng2013 ER - TY - STD TI - Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes. http://clinicaltrials.gov/ct2/show/NCT01289119. Accessed Aug 2014. UR - http://clinicaltrials.gov/ct2/show/NCT01289119 ID - ref17 ER - TY - JOUR AU - Chen, Y. AU - Ning, G. AU - Wang, C. AU - Gong, Y. AU - Patel, S. AU - Zhang, C. AU - Izumoto, T. AU - Woerle, H. -. J. AU - Wang, W. PY - 2015 DA - 2015// TI - Efficacy and safety of linagliptin monotherapy in Asian patients with inadequately controlled type 2 diabetes mellitus: A multinational, 24-week, randomized, clinical trial JO - J Diabetes Investig VL - 6 UR - https://doi.org/10.1111/jdi.12346 DO - 10.1111/jdi.12346 ID - Chen2015 ER - TY - JOUR AU - Ning, G. AU - Wang, W. AU - Li, L. AU - Ma, J. AU - Lv, X. AU - Yang, M. AU - Wang, W. AU - Woloschak, M. AU - Lukashevich, V. AU - Kothny, W. PY - 2016 DA - 2016// TI - Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus JO - J Diabetes VL - 8 UR - https://doi.org/10.1111/1753-0407.12303 DO - 10.1111/1753-0407.12303 ID - Ning2016 ER - TY - JOUR AU - Rosenstock, J. AU - Rendell, M. S. AU - Gross, J. L. AU - Fleck, P. R. AU - Wilson, C. A. AU - Mekki, Q. PY - 2009 DA - 2009// TI - Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia JO - Diabetes Obes Metab VL - 11 UR - https://doi.org/10.1111/j.1463-1326.2009.01124.x DO - 10.1111/j.1463-1326.2009.01124.x ID - Rosenstock2009 ER - TY - JOUR AU - Nauck, M. A. AU - Ellis, G. C. AU - Fleck, P. R. AU - Wilson, C. A. AU - Mekki, Q. PY - 2009 DA - 2009// TI - Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study JO - Int J Clin Pract VL - 63 UR - https://doi.org/10.1111/j.1742-1241.2008.01933.x DO - 10.1111/j.1742-1241.2008.01933.x ID - Nauck2009 ER - TY - JOUR AU - Raz, I. AU - Hanefeld, M. AU - Xu, L. AU - Caria, C. AU - Williams-Herman, D. AU - Khatami, H. PY - 2006 DA - 2006// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus JO - Diabetologia VL - 49 UR - https://doi.org/10.1007/s00125-006-0416-z DO - 10.1007/s00125-006-0416-z ID - Raz2006 ER - TY - JOUR AU - Aschner, P. AU - Kipnes, M. S. AU - Lunceford, J. K. PY - 2006 DA - 2006// TI - Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/dc06-0703 DO - 10.2337/dc06-0703 ID - Aschner2006 ER - TY - JOUR AU - Hanefeld, M. AU - Herman, G. A. AU - Wu, M. AU - Mickel, C. AU - Sanchez, M. AU - Stein, P. P. PY - 2007 DA - 2007// TI - Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes JO - Curr Med Res Opin VL - 23 UR - https://doi.org/10.1185/030079907X188152 DO - 10.1185/030079907X188152 ID - Hanefeld2007 ER - TY - JOUR AU - Goldstein, B. J. AU - Feinglos, M. N. AU - Lunceford, J. K. PY - 2007 DA - 2007// TI - Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes JO - Diabetes Care VL - 30 UR - https://doi.org/10.2337/dc07-0627 DO - 10.2337/dc07-0627 ID - Goldstein2007 ER - TY - JOUR AU - Charbonnel, B. AU - Karasik, A. AU - Liu, J. AU - Wu, M. AU - Meininger, G. PY - 2006 DA - 2006// TI - Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone JO - Dia Care VL - 29 UR - https://doi.org/10.2337/dc06-0706 DO - 10.2337/dc06-0706 ID - Charbonnel2006 ER - TY - JOUR AU - Raz, I. AU - Chen, Y. AU - Wu, M. AU - Hussain, S. AU - Kaufman, K. D. AU - Amatruda, J. M. AU - Langdon, R. B. AU - Stein, P. P. AU - ALBA, M. PY - 2008 DA - 2008// TI - Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes JO - Curr Med Res Opin VL - 24 UR - https://doi.org/10.1185/030079908X260925 DO - 10.1185/030079908X260925 ID - Raz2008 ER - TY - JOUR AU - Rosenstock, J. AU - Brazg, R. AU - Andryuk, P. J. AU - Lu, K. AU - Stein, P. PY - 2006 DA - 2006// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study JO - Clin Ther VL - 28 UR - https://doi.org/10.1016/j.clinthera.2006.10.007 DO - 10.1016/j.clinthera.2006.10.007 ID - Rosenstock2006 ER - TY - JOUR AU - Hermansen, K. AU - Kipnes, M. AU - Luo, E. AU - Fanurik, D. AU - Khatami, H. AU - Stein, P. PY - 2007 DA - 2007// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2007.00744.x DO - 10.1111/j.1463-1326.2007.00744.x ID - Hermansen2007 ER - TY - JOUR AU - Vilsbøll, T. AU - Rosenstock, J. AU - Yki Järvinen, H. AU - Cefalu, W. T. AU - Chen, Y. AU - Luo, E. AU - Musser, B. AU - Andryuk, P. J. AU - Ling, Y. AU - Kaufman, K. D. AU - Amatruda, J. M. AU - Engel, S. S. AU - Katz, L. PY - 2010 DA - 2010// TI - Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes JO - Diabetes Obes Metab VL - 12 UR - https://doi.org/10.1111/j.1463-1326.2009.01173.x DO - 10.1111/j.1463-1326.2009.01173.x ID - Vilsbøll2010 ER - TY - JOUR AU - Scott, R. AU - Wu, M. AU - Sanchez, M. AU - Stein, P. PY - 2007 DA - 2007// TI - Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes JO - Int J Clin Pract VL - 61 UR - https://doi.org/10.1111/j.1742-1241.2006.01246.x DO - 10.1111/j.1742-1241.2006.01246.x ID - Scott2007 ER - TY - JOUR AU - Scott, R. AU - Loeys, T. AU - Davies, M. J. AU - Engel, S. S. PY - 2008 DA - 2008// TI - Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes* JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2007.00839.x DO - 10.1111/j.1463-1326.2007.00839.x ID - Scott2008 ER - TY - JOUR AU - Ristic, S. AU - Byiers, S. AU - Foley, J. AU - Holmes, D. PY - 2005 DA - 2005// TI - Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response JO - Diabetes Obes Metab VL - 7 UR - https://doi.org/10.1111/j.1463-1326.2005.00539.x DO - 10.1111/j.1463-1326.2005.00539.x ID - Ristic2005 ER - TY - STD TI - Dejager S, Razac S, Foley JE, Schweizer A. Vildagliptin in drug-na ï ve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study. Horm Metab Res. 2007. ID - ref34 ER - TY - JOUR AU - Pi-Sunyer, F. X. AU - Schweizer, A. AU - Mills, D. AU - Dejager, S. PY - 2007 DA - 2007// TI - Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes JO - Diabetes Res Clin Pract VL - 76 UR - https://doi.org/10.1016/j.diabres.2006.12.009 DO - 10.1016/j.diabres.2006.12.009 ID - Pi-Sunyer2007 ER - TY - JOUR AU - Bosi, E. AU - Camisasca, R. P. AU - Collober, C. AU - Rochotte, E. AU - Garber, A. J. PY - 2007 DA - 2007// TI - Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin JO - Dia Care VL - 30 UR - https://doi.org/10.2337/dc06-1732 DO - 10.2337/dc06-1732 ID - Bosi2007 ER - TY - JOUR AU - Garber, A. J. AU - Schweizer, A. AU - Baron, M. A. AU - Rochotte, E. AU - Dejager, S. PY - 2007 DA - 2007// TI - Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study* JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2006.00684.x DO - 10.1111/j.1463-1326.2006.00684.x ID - Garber2007 ER - TY - JOUR AU - Garber, A. J. AU - Foley, J. E. AU - Banerji, M. A. AU - Ebeling, P. AU - Gudbjörnsdottir, S. AU - Camisasca, R. P. AU - Couturier, A. AU - Baron, M. A. PY - 2008 DA - 2008// TI - Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea* JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00859.x DO - 10.1111/j.1463-1326.2008.00859.x ID - Garber2008 ER - TY - JOUR AU - Fonseca, V. AU - Schweizer, A. AU - Albrecht, D. AU - Baron, M. A. AU - Chang, I. AU - Dejager, S. PY - 2007 DA - 2007// TI - Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes JO - Diabetologia VL - 50 UR - https://doi.org/10.1007/s00125-007-0633-0 DO - 10.1007/s00125-007-0633-0 ID - Fonseca2007 ER - TY - JOUR AU - DeFronzo, R. A. AU - Hissa, M. N. AU - Garber, A. J. AU - Gross, J. L. AU - Duan, R. Y. AU - Ravichandran, S. AU - Chen, R. S. PY - 2009 DA - 2009// TI - The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone JO - Dia Care VL - 32 UR - https://doi.org/10.2337/dc08-1984 DO - 10.2337/dc08-1984 ID - DeFronzo2009 ER - TY - JOUR AU - Prato, S. AU - Barnett, A. H. AU - Huisman, H. AU - Neubacher, D. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2011 DA - 2011// TI - Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01350.x DO - 10.1111/j.1463-1326.2010.01350.x ID - Prato2011 ER - TY - JOUR AU - Taskinen, M. R. AU - Rosenstock, J. AU - Tamminen, I. AU - Kubiak, R. AU - Patel, S. AU - Dugi, K. A. AU - Woerle, H. J. PY - 2011 DA - 2011// TI - Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01326.x DO - 10.1111/j.1463-1326.2010.01326.x ID - Taskinen2011 ER - TY - STD TI - Moses RG, Round E, Shentu Y, Golm GT, O’neill EA, Gantz I, Engel SS, Kaufman KD, Goldstein BJ. A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control. J Diabetes. 2015. doi:10.1111/1753-0407.12351. ID - ref43 ER - TY - JOUR AU - Laakso, M. AU - Rosenstock, J. AU - Groop, P. H. AU - Barnett, A. H. PY - 2015 DA - 2015// TI - Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial JO - Diabetes Care VL - 38 UR - https://doi.org/10.2337/dc14-1684 DO - 10.2337/dc14-1684 ID - Laakso2015 ER - TY - JOUR AU - White, J. L. AU - Buchanan, P. AU - Li, J. AU - Frederich, R. PY - 2014 DA - 2014// TI - A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy JO - BMC Endocr Disord VL - 14 UR - https://doi.org/10.1186/1472-6823-14-17 DO - 10.1186/1472-6823-14-17 ID - White2014 ER - TY - JOUR AU - Moses, R. G. AU - Kalra, S. AU - Brook, D. AU - Sockler, J. AU - Monyak, J. AU - Visvanathan, J. AU - Montanaro, M. AU - Fisher, S. A. PY - 2014 DA - 2014// TI - A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12234 DO - 10.1111/dom.12234 ID - Moses2014 ER - TY - JOUR AU - Bajaj, M. AU - Gilman, R. AU - Patel, S. AU - Kempthorne Rawson, J. AU - Lewis D’Agostino, D. AU - Woerle, H. J. PY - 2014 DA - 2014// TI - Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study JO - Diabet Med VL - 31 UR - https://doi.org/10.1111/dme.12495 DO - 10.1111/dme.12495 ID - Bajaj2014 ER - TY - JOUR AU - Fonseca, V. AU - Staels, B. AU - Morgan, J. D. AU - Shentu, Y. AU - Golm, G. T. AU - Johnson Levonas, A. O. AU - kaufman, K. D. AU - Goldstein, B. J. AU - Steinberg, H. PY - 2013 DA - 2013// TI - Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes JO - J Diabetes Complicat VL - 27 UR - https://doi.org/10.1016/j.jdiacomp.2012.09.007 DO - 10.1016/j.jdiacomp.2012.09.007 ID - Fonseca2013 ER - TY - JOUR AU - Kothny, W. AU - Foley, J. AU - Kozlovski, P. AU - Shao, Q. AU - Gallwitz, B. AU - Lukashevich, V. PY - 2013 DA - 2013// TI - Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus JO - Diabetes Obes Metab VL - 15 UR - https://doi.org/10.1111/dom.12020 DO - 10.1111/dom.12020 ID - Kothny2013 ER - TY - JOUR AU - Dobs, A. S. AU - Goldstein, B. J. AU - Aschner, P. AU - Horton, E. S. AU - Umpierrez, G. E. AU - Duran, L. AU - Hill, J. S. AU - Chen, Y. AU - Golm, G. T. AU - Langdon, R. B. AU - Williams Herman, D. E. AU - Kaufman, K. D. AU - Amatruda, J. M. AU - Ferreira, J. C. A. PY - 2013 DA - 2013// TI - Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes JO - J Diabetes VL - 5 UR - https://doi.org/10.1111/j.1753-0407.2012.00223.x DO - 10.1111/j.1753-0407.2012.00223.x ID - Dobs2013 ER - TY - JOUR AU - Lewin, A. J. AU - Arvay, L. AU - Liu, D. AU - Patel, S. AU - Eynatten Von, M. AU - Woerle, H. -. J. PY - 2012 DA - 2012// TI - Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial JO - Clin Ther VL - 34 UR - https://doi.org/10.1016/j.clinthera.2012.07.008 DO - 10.1016/j.clinthera.2012.07.008 ID - Lewin2012 ER - TY - JOUR AU - Barnett, A. H. AU - Patel, S. AU - Harper, R. AU - Toorawa, R. AU - Thiemann, S. AU - Eynatten, M. AU - Woerle, H. J. PY - 2012 DA - 2012// TI - Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/dom.12011 DO - 10.1111/dom.12011 ID - Barnett2012 ER - TY - JOUR AU - Forst, T. AU - Uhlig Laske, B. AU - Ring, A. AU - Graefe Mody, U. AU - Friedrich, C. AU - Herbach, K. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2010 DA - 2010// TI - Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes JO - Diabet Med VL - 27 UR - https://doi.org/10.1111/j.1464-5491.2010.03131.x DO - 10.1111/j.1464-5491.2010.03131.x ID - Forst2010 ER - TY - JOUR AU - Nowicki, M. AU - Rychlik, I. AU - Haller, H. AU - Warren, M. L. AU - Suchower, L. AU - Gause Nilsson, I. PY - 2011 DA - 2011// TI - Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01382.x DO - 10.1111/j.1463-1326.2011.01382.x ID - Nowicki2011 ER - TY - JOUR AU - Gomis, R. AU - Espadero, R. M. AU - Jones, R. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2011 DA - 2011// TI - Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01391.x DO - 10.1111/j.1463-1326.2011.01391.x ID - Gomis2011 ER - TY - JOUR AU - Hollander, P. AU - Li, J. AU - Allen, E. AU - Chen, R. PY - 2011 DA - 2011// TI - Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone JO - J Clin Endocrinol Metab VL - 94 UR - https://doi.org/10.1210/jc.2009-0550 DO - 10.1210/jc.2009-0550 ID - Hollander2011 ER - TY - JOUR AU - Pratley, R. E. AU - Kipnes, M. S. AU - Fleck, P. R. AU - Wilson, C. AU - Mekki, Q. PY - 2009 DA - 2009// TI - Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy JO - Diabetes Obes Metab VL - 11 UR - https://doi.org/10.1111/j.1463-1326.2008.01016.x DO - 10.1111/j.1463-1326.2008.01016.x ID - Pratley2009 ER - TY - STD TI - Pratley RE, Holmes D. Twelve − week Monotherapy with the DPP− 4 Inhibitor Vildagliptin Improves Glycemic Control in Subjects with Type 2 Diabetes. Horm Metab Res. 2006. ID - ref58 ER - TY - JOUR AU - Nonaka, K. AU - Kakikawa, T. AU - Sato, A. AU - Okuyama, K. AU - Fujimoto, G. AU - Kato, N. AU - Suzuki, H. AU - Hirayama, Y. AU - Ahmed, T. AU - Davies, M. J. AU - Stein, P. P. PY - 2008 DA - 2008// TI - Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes JO - Diabetes Res Clin Pract VL - 79 UR - https://doi.org/10.1016/j.diabres.2007.08.021 DO - 10.1016/j.diabres.2007.08.021 ID - Nonaka2008 ER - TY - JOUR AU - Kikuchi, M. AU - Abe, N. AU - Kato, M. AU - Terao, S. AU - Mimori, N. AU - Tachibana, H. PY - 2009 DA - 2009// TI - Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus JO - Diabetes Res Clin Pract VL - 83 UR - https://doi.org/10.1016/j.diabres.2008.10.006 DO - 10.1016/j.diabres.2008.10.006 ID - Kikuchi2009 ER - TY - JOUR AU - Iwamoto, Y. AU - Taniguchi, T. AU - Nonaka, K. AU - Okamoto, T. AU - Okuyama, K. AU - Ferreira, J. C. A. AU - Amatruda, J. PY - 2010 DA - 2010// TI - Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus JO - Endocr J VL - 57 UR - https://doi.org/10.1507/endocrj.K09E-272 DO - 10.1507/endocrj.K09E-272 ID - Iwamoto2010 ER - TY - JOUR AU - Kikuchi, M. AU - Haneda, M. AU - Koya, D. AU - Tobe, K. AU - Onishi, Y. AU - Couturier, A. AU - Mimori, N. AU - Inaba, Y. AU - Goodman, M. PY - 2010 DA - 2010// TI - Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus JO - Diabetes Res Clin Pract VL - 89 UR - https://doi.org/10.1016/j.diabres.2010.04.017 DO - 10.1016/j.diabres.2010.04.017 ID - Kikuchi2010 ER - TY - JOUR AU - Kaku, K. AU - Itayasu, T. AU - Hiroi, S. AU - Hirayama, M. AU - Seino, Y. PY - 2011 DA - 2011// TI - Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2011.01460.x DO - 10.1111/j.1463-1326.2011.01460.x ID - Kaku2011 ER - TY - STD TI - Kashiwagi A, Kadowaki T, Tajima N, Nonaka K, Taniguchi T, Nishii M, Ferreira JCA, Amatruda JM. Sitagliptin added to treatment with ongoing pioglitazone for up to 52weeks improves glycemic control in Japanese patients with type 2 diabetes. J Diabetes Investig. 2011;2:381–90. ID - ref64 ER - TY - JOUR AU - Seino, Y. AU - Fujita, T. AU - Hiroi, S. AU - Hirayama, M. AU - Kaku, K. PY - 2011 DA - 2011// TI - Alogliptin plus voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension JO - Curr Med Res Opin VL - 27 UR - https://doi.org/10.1185/03007995.2011.614936 DO - 10.1185/03007995.2011.614936 ID - Seino2011 ER - TY - JOUR AU - Kawamori, R. AU - Inagaki, N. AU - Araki, E. AU - Watada, H. AU - Hayashi, N. AU - Horie, Y. AU - Sarashina, A. AU - Gong, Y. AU - Eynatten, M. AU - Woerle, H. J. AU - Dugi, K. A. PY - 2012 DA - 2012// TI - Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2011.01545.x DO - 10.1111/j.1463-1326.2011.01545.x ID - Kawamori2012 ER - TY - JOUR AU - Seino, Y. AU - Miyata, Y. AU - Hiroi, S. AU - Hirayama, M. AU - Kaku, K. PY - 2012 DA - 2012// TI - Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01620.x DO - 10.1111/j.1463-1326.2012.01620.x ID - Seino2012 ER - TY - JOUR AU - Seino, Y. AU - Hiroi, S. AU - Hirayama, M. AU - Kaku, K. PY - 2012 DA - 2012// TI - Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study JO - J Diabetes Investig VL - 3 UR - https://doi.org/10.1111/j.2040-1124.2012.00226.x DO - 10.1111/j.2040-1124.2012.00226.x ID - Seino2012 ER - TY - JOUR AU - Kadowaki, T. AU - Tajima, N. AU - Odawara, M. AU - Nishii, M. AU - Taniguchi, T. AU - Ferreira, J. C. A. PY - 2013 DA - 2013// TI - Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks JO - J Diabetes Investig VL - 4 UR - https://doi.org/10.1111/jdi.12001 DO - 10.1111/jdi.12001 ID - Kadowaki2013 ER - TY - JOUR AU - Kaku, K. AU - Mori, M. AU - Kanoo, T. AU - Katou, M. AU - Seino, Y. PY - 2014 DA - 2014// TI - Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase JO - Expert Opin Pharmacother VL - 15 UR - https://doi.org/10.1517/14656566.2014.956722 DO - 10.1517/14656566.2014.956722 ID - Kaku2014 ER - TY - JOUR AU - Odawara, M. AU - Hamada, I. AU - Suzuki, M. PY - 2014 DA - 2014// TI - Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus JO - Diabetes Ther VL - 5 UR - https://doi.org/10.1007/s13300-014-0059-x DO - 10.1007/s13300-014-0059-x ID - Odawara2014 ER - TY - JOUR AU - Hirose, T. AU - Suzuki, M. AU - Tsumiyama, I. PY - 2015 DA - 2015// TI - Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study JO - Diabetes Ther VL - 6 UR - https://doi.org/10.1007/s13300-015-0147-6 DO - 10.1007/s13300-015-0147-6 ID - Hirose2015 ER - TY - JOUR AU - Tajima, N. AU - Kadowaki, T. AU - Okamoto, T. AU - Sato, A. AU - Okuyama, K. AU - Minamide, T. AU - Arjona Ferreira, J. C. PY - 2013 DA - 2013// TI - Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes JO - J Diabetes Investig VL - 4 UR - https://doi.org/10.1111/jdi.12116 DO - 10.1111/jdi.12116 ID - Tajima2013 ER - TY - JOUR AU - Kadowaki, T. AU - Tajima, N. AU - Odawara, M. AU - Minamide, T. AU - Kawashima, M. AU - Yanagida, D. AU - Okamoto, T. AU - Ferreira, J. C. A. PY - 2013 DA - 2013// TI - Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy JO - Diabetol Int VL - 4 UR - https://doi.org/10.1007/s13340-013-0109-z DO - 10.1007/s13340-013-0109-z ID - Kadowaki2013 ER - TY - JOUR AU - Tajima, N. AU - Kadowaki, T. AU - Odawara, M. AU - Nishii, M. AU - Taniguchi, T. AU - Ferreira, J. C. A. PY - 2011 DA - 2011// TI - Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control JO - Diabetol Int VL - 2 UR - https://doi.org/10.1007/s13340-011-0022-2 DO - 10.1007/s13340-011-0022-2 ID - Tajima2011 ER - TY - STD TI - World Health Organization. World Health Statistics 2015. 2015. ID - ref76 ER - TY - JOUR AU - Xie, W. AU - Zhao, Y. AU - Zhang, Y. PY - 2011 DA - 2011// TI - Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus JO - Evid Based Complement Alternat Med VL - 2011 ID - Xie2011 ER -